First Time Loading...
N

Nuoncology Labs Inc
OTC:NLAB

Watchlist Manager
Nuoncology Labs Inc
OTC:NLAB
Watchlist
Price: 297 USD Market Closed
Updated: May 9, 2024

Nuoncology Labs Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Nuoncology Labs Inc
Revenue Peer Comparison

Comparables:
MEG
DMTK
SHC
SERA
S
SPEC

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
N
Nuoncology Labs Inc
OTC:NLAB
Revenue
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Montrose Environmental Group Inc
NYSE:MEG
Revenue
$624.2m
CAGR 3-Years
24%
CAGR 5-Years
27%
CAGR 10-Years
N/A
DermTech Inc
NASDAQ:DMTK
Revenue
$15.3m
CAGR 3-Years
37%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sotera Health Co
NASDAQ:SHC
Revenue
$1B
CAGR 3-Years
9%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Sera Prognostics Inc
NASDAQ:SERA
Revenue
$306k
CAGR 3-Years
117%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Spectaire Holdings Inc
NASDAQ:SPEC
Revenue
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Nuoncology Labs Inc's Revenue?
Revenue
0 USD

Based on the financial report for Dec 31, 2021, Nuoncology Labs Inc's Revenue amounts to 0 USD.